DePuy Synthes Announces CE Mark for BI-MENTUM Dual Mobility Hip

DePuy Synthes has been informed of CE Mark approval for the BI-MENTUM™ Dual Mobility hip for patients with a higher risk of dislocation. In addition to the burden of repeat surgeries, surgical treatment of a dislocating total hip can reportedly raise the cost of hip replacement by 342%.

BI-MENTUM features a standard femoral head articulating...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us